Hospital Universitario de Donostia-ko ikertzaileekin lankidetzan egindako argitalpenak (14)

2024

  1. Metabolomic profile of neuroendocrine tumors identifies methionine, porphyrin, and tryptophan metabolisms as key dysregulated pathways associated with patient survival

    European Journal of Endocrinology, Vol. 190, Núm. 1, pp. 62-74

2023

  1. Identification of fatty acid amide hydrolase as a metastasis suppressor in breast cancer

    Nature Communications, Vol. 14, Núm. 1

2022

  1. Sample size requirement in trials that use the composite endpoint major adverse cardiovascular events (MACE): new insights

    Trials, Vol. 23, Núm. 1

2021

  1. Author Correction: Genetic landscape of 6089 inherited retinal dystrophies affected cases in Spain and their therapeutic and extended epidemiological implications (Scientific Reports, (2021), 11, 1, (1526), 10.1038/s41598-021-81093-y)

    Scientific Reports

  2. Follow-up care over 12months of patients with prostate cancer in Spain A multicenter prospective cohort study

    Medicine (United States), Vol. 100, Núm. 47

  3. Genetic landscape of 6089 inherited retinal dystrophies affected cases in Spain and their therapeutic and extended epidemiological implications

    Scientific Reports, Vol. 11, Núm. 1

  4. Prognostic models for mortality after cardiac surgery in patients with infective endocarditis: a systematic review and aggregation of prediction models

    Clinical Microbiology and Infection, Vol. 27, Núm. 10, pp. 1422-1430

  5. The pseudokinase TRIB3 negatively regulates the HER2 receptor pathway and is a biomarker of good prognosis in luminal breast cancer

    Cancers, Vol. 13, Núm. 21

2018

  1. Individual data meta-analysis for the study of survival after pulmonary metastasectomy in colorectal cancer patients: A history of resected liver metastases worsens the prognosis

    European Journal of Surgical Oncology, Vol. 44, Núm. 7, pp. 1006-1012

2015

  1. Assessment of the reproducibility of oligoclonal IgM band detection for its application in daily clinical practice

    Clinica Chimica Acta, Vol. 438, pp. 67-69

2014

  1. A phase 2 trial of the GSK-3 inhibitor tideglusib in progressive supranuclear palsy

    Movement Disorders, Vol. 29, Núm. 4, pp. 470-478

  2. Bladder cancer index: Cross-cultural adaptation into Spanish and psychometric evaluation

    Health and Quality of Life Outcomes, Vol. 12, Núm. 1

2011

  1. Utility of oligoclonal IgG band detection for MS diagnosis in daily clinical practice

    Journal of Immunological Methods, Vol. 371, Núm. 1-2, pp. 170-173

2003

  1. Characterization of a 6p21 translocation breakpoint in a family with idiopathic generalized epilepsy

    Epilepsy Research, Vol. 56, Núm. 2-3, pp. 155-163